|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 根据基础降压用药分析恩格列净在2型糖尿病合并高血压患者中的降压作用显示文摘在EMPA—REG血压试验中,与安慰剂比较,恩格列净(empagliflozin)10或25mg/d可降低2型糖尿病合并高血压患者的糖化血红蛋白、血压及体质量水平。 | Mancia G Cannon CP Tikkanen I Zeller C Ley L Woerle HJ Broedl UC Johansen OE 赵狄 练桂丽 | 2016 | 中华高血压杂志2016，24，10： | 3 |
| 2 | Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus显示文摘 | David Z.I. Cherney Bruce A. Perkins Nima Soleymanlou Maria Maione Vesta Lai Alana Lee Nora M. Fagan Hans J. Woerle Odd Erik Johansen Uli C. Broedl Maximilian von Eynatten | 2014 | Circulation2014，，： | 2 |
| 3 | 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial显示文摘 | Baptist Gallwitz Julio Rosenstock Thomas Rauch Sudipta Bhattacharya Sanjay Patel Maximilian von Eynatten Klaus A Dugi Hans-Juergen Woerle | 2012 | The Lancet2012，，9840： | 2 |
| 4 | Pharmacokinetics of linagliptin in subjects with hepatic impairment显示文摘 | Ulrike Graefe‐Mody Peter Rose Silke Retlich Arne Ring Lisa Waldhauser Rodica Cinca Hans‐Juergen Woerle | 2012 | British Journal of Clinical Pharmacology2012，，1： | 2 |
| 5 | Diagnostic and therapeutic implications of relationships between fasting, 2 hour postchallenge plasma glucose and hemoglobin Alc values 显示文摘 | Woerle H J Pimenta WP Meyer C | 2004 | Arch Intern Med2004，164，15： | 1 |
| 6 | Everolimus for the treatment of subependyraal giant cell astroeytoma probably causing seizure aggravation in a child with tuberous sclerosis complex: a case report 显示文摘 | Wiemer-Kruel A Woerle H Strobl K | 2014 | Neuropediatrics2014，45，2： | 1 |
| 7 | Importance of postprandial glycemia to achieve target HbA1c levels显示文摘 | Woerle HJ Neumann C Zschau S Impart of fasting and postprandial glycemia On overall glycemic control in ty pe 2 diabetes | 2007 | Diabetes Res Clin Pract2007，77，2： | 1 |
| 8 | Efficacy and safety of linagliptin added to metformin and sulphonylurea in Chinese patients with type 2 diabetes: a sub-analysis of data from a randomised clinical trial显示文摘 | Zhengpei Zeng Jin-Kui Yang Nanwei Tong Shengli Yan Xiling Zhang Yan Gong Hans-Juergen Woerle | 2013 | Current Medical Research & Opinion2013，，8： | 1 |
| 9 | Efficacy and Tolerability of Linagliptin Added to a Sulfonylurea Regimen in Patients With Inadequately Controlled Type 2 Diabetes Mellitus: An 18-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial显示文摘 | Andrew J. Lewin Lisa Arvay Dacheng Liu Sanjay Patel Maximilian von Eynatten Hans-Juergen Woerle | 2012 | Clinical Therapeutics2012，，9： | 1 |
| 10 | GLP-1 regulates gastroduodenal motility involving cholinergic pathways显示文摘 | Schirra J Nicolaus M Woerle HJ | 2009 | Neurogastroenterol Motil2009，21，6： | 1 |
| 11 | Pharmacokinetics of linagliptin in subjects with hepatic impairment显示文摘 | Ulrike Graefe‐Mody Peter Rose Silke Retlich Arne Ring Lisa Waldhauser Rodica Cinca Hans‐Juergen Woerle | 2012 | British Journal of Clinical Pharmacology2012，，1： | 1 |
| 12 | Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes显示文摘 | Woerle HJ Neumann C Zschau S | | 0，，02： | 1 |
| 13 | Impact of fasting andpostprandial glycemia on overall glycemic control in type 2diabetes importance of postprandial glycemia to achieve targetHbAlc levels显示文摘 | Woerle HJ Neumann C Zschau S | 2007 | Diabetes Res Clin Pract2007，77，2： | 1 |
| 14 | Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes: importance of postprandial glycemia to achieve target HbA 1 c levels显示文摘 | Woerle HJ Neumann C Zschau S | 2007 | Diabetes Res Clin Pract2007，77，2： | 1 |
| 15 | Impactof empagliflozin added-on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo- controlled trial显示文摘 | Rosenstock J Jelaska A Zeller C Kim G Broedl UC Woerle HJ | 2015 | Diabetes Obes Metab2015，17，10： | 1 |
| 16 | Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes显示文摘 | Rosenstock J Jelaska A Frappin G Salsali A Kim G Woerle H J Broedl UC | 2014 | Diabetes Care2014，37，： | 1 |
| 17 | Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans显示文摘 | MEYER C PIMENTA W WOERLE H J et at | 2006 | Diabetes Care2006，29，8： | 1 |
| 18 | Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension显示文摘 | Tikkanen I Narko K Zeller C Green A Salsali A Broedl UC Woerle HJ | 2015 | Diabetes Care2015，38，： | 1 |
| 19 | Renal impairment has no relevant effect on long- term exposure of linagliptin in patients with type 2 diabetes mellitus显示文摘 | FRIEDRICH C EMSER A WOERLE HJ | 2011 | Diabetes2011，601，： | 1 |
| 20 | Impact of fasting and post- prandial glycemia on overall glycemic control in type 2 diabetes Im- portance of postprandial glycemia to achieve target HbA1C levels 显示文摘 | Woerle H J Neumann C Zschan S | 2007 | Diabetes Res Clin Pract2007，77，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员